IP Library Patent Application 11708109
Patent Application
App. No. 11/708,109

Methods of detecting a target nucleic acid

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/708,109
Abstract

The invention relates to compositions and methods of generating a signal indicative of the presence of a target nucleic acid in a sample, where the method includes forming a cleavage structure by incubating a sample comprising a target nucleic acid with a probe. The invention also includes the steps of cleaving the cleavage structure with a nuclease to release a nucleic acid fragment to generate a signal, wherein generation of the signal is indicative of the presence of a target nucleic acid in a sample.

Claims (14)

1 - 48 . (canceled)

49 . A method of detecting a nucleic acid molecule, comprising: a) exposing a sample comprising a target nucleic acid molecule to a purified thermostable FEN-1 endonuclease to generate a cleavage product; and b) detecting said cleavage product.

50 . The method of claim 49 , wherein said cleavage product is produced from a probe oligonucleotide hybridized to said target nucleic acid.

51 . The method of claim 49 , wherein step a) comprises: exposing said sample to said purified thermostable FEN-1 endonuclease and a polymerase.

52 . The method of claim 51 , wherein said polymerase comprises a template-dependent polymerase.

53 . The method of claim 49 , wherein said detecting comprises detection of fluorescence.

54 . The method of claim 49 , wherein said target nucleic acid comprises synthetic target nucleic acid.

55 . The method of claim 54 , wherein said synthetic target nucleic comprises an amplified nucleic acid.

56 . The method of claim 55 , wherein said amplified nucleic acid is produced using a polymerase chain reaction.

57 . The method of claim 49 , wherein said method is conducted under isothermal conditions.

58 . The method of claim 49 , wherein said exposing comprises hybridizing first and second nucleic acid molecules to said target nucleic acid.

59 . The method of claim 49 , wherein said detecting comprises detecting a non-target cleavage product.

60 . The method of claim 49 , wherein said thermostable FEN-1 endonuclease comprises a FEN-1 endonuclease from an archaebacterial species.

61 . The method of claim 60 , wherein said archaeal FEN-1 endonuclease comprises a FEN-1 endonuclease from Pyrococcus furiosus.

Assignments (4)
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
EIGHTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Mar 26, 2009
From: CYTYC CORPORATION; HOLOGIC, INC.
To: GOLDMAN SACHS CREDIT PARTNERSL.P.
Reel/Frame 022456/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2008
From: STRATAGENE CALIFORNIA
To: HOLOGIC INC.
Reel/Frame 021976/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2007
From: SORGE, JOSEPH A.
To: STRATAGENE CALIFORNIA
Reel/Frame 019418/0513 →